Influence of Genetic Background and Tissue Types on Global DNA Methylation Patterns

Recent studies have shown a genetic influence on gene expression variation, chromatin, and DNA methylation. However, the effects of genetic background and tissue types on DNA methylation at the genome-wide level have not been characterized extensively. To study the effect of genetic background and tissue types on global DNA methylation, we performed DNA methylation analysis using the Affymetrix 500K SNP array on tumor, adjacent normal tissue, and blood DNA from 30 patients with esophageal squamous cell carcinoma (ESCC). The use of multiple tissues from 30 individuals allowed us to evaluate variation of DNA methylation states across tissues and individuals. Our results demonstrate that blood and esophageal tissues shared similar DNA methylation patterns within the same individual, suggesting an influence of genetic background on DNA methylation. Furthermore, we showed that tissue types are important contributors of DNA methylation states.

[1]  Kenny Q. Ye,et al.  Comparative isoschizomer profiling of cytosine methylation: the HELP assay. , 2006, Genome research.

[2]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[3]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[4]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[5]  J. Rowley,et al.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Buetow,et al.  Allele-Specific Chromatin Immunoprecipitation Studies Show Genetic Influence on Chromatin State in Human Genome , 2007, PLoS genetics.

[7]  Michael L. Cleary,et al.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.

[8]  P. Visscher,et al.  DNA methylation profiles in monozygotic and dizygotic twins , 2009, Nature Genetics.

[9]  B. Tycko,et al.  Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation , 2008, Nature Genetics.

[10]  A. Feinberg,et al.  Intra-individual change over time in DNA methylation with familial clustering. , 2008, JAMA.

[11]  K. Buetow,et al.  Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array , 2006, BMC Genomics.

[12]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[13]  B. Tycko,et al.  A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons. , 2006, Cancer research.

[14]  Rafael A Irizarry,et al.  Comprehensive high-throughput arrays for relative methylation (CHARM). , 2008, Genome research.

[15]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[16]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[17]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[18]  J. Chang-Claude,et al.  Familial aggregation of oesophageal cancer in a high incidence area in China. , 1997, International journal of epidemiology.

[19]  B. Horsthemke,et al.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma , 1989, Human Genetics.

[20]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[21]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[22]  Wei Jiang,et al.  High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.

[23]  Ling Li,et al.  Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. , 2002, Cancer letters.

[24]  Nan Hu,et al.  Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. , 2009, Cancer research.

[25]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[26]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[27]  N. Hu,et al.  Family history of oesophageal cancer in Shanxi Province, China. , 1991, European journal of cancer.

[28]  N. Hu,et al.  Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  M. Esteller.  Relevance of DNA methylation in the management of cancer. , 2003, The Lancet. Oncology.

[30]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Huang,et al.  Methylation profiling of CpG islands in human breast cancer cells. , 1999, Human molecular genetics.

[32]  A. Bird,et al.  Reading the DNA methylation signal. , 2004, Cold Spring Harbor symposia on quantitative biology.